{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-036781","form_type":"8-K","ticker":"OCGN","cik":"0001372299","company_name":"Ocugen, Inc.","filed_at":"2022-03-23T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.189018+00:00","generated_at":"2026-06-26T19:31:50.696944+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Ocugen director Manish Potti not standing for re-election; board adds Marna Whittington, new CAO employment deal","bullets":["Manish Potti, Class II director, will not stand for re-election at 2022 annual meeting; no disagreement cited.","Board expanded from 7 to 8; Marna Whittington appointed Class II director effective March 21, 2022; board to shrink to 7 after annual meeting.","Dr. Whittington receives initial option grant with grant date fair value $285,000, vesting over three years.","CAO Jessica Crespo enters amended employment agreement with base salary $375,000 and target bonus 40% of base salary.","Crespo awarded stock option ($225,000 fair value) and RSUs ($75,000 fair value), both vesting over three years."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-036781","json":"https://secwatch.observer/filing/0001104659-22-036781.json","markdown":"https://secwatch.observer/filing/0001104659-22-036781.md","text":"https://secwatch.observer/filing/0001104659-22-036781.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372299/000110465922036781/0001104659-22-036781-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372299/000110465922036781/tm2210190d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T19:31:50.696944+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"29f6682fb7","claim":"Manish Potti departed as Class II Director at Ocugen, Inc..","evidence_excerpt":"On March 17, 2022, Manish Potti, a member of the Board of Directors (the “Board”) of Ocugen, Inc. (the “Company”), notified the Board that he will not stand for re-election as a Class II director at the Company’s 2022 annual meeting of stockholders (the “Annual Meeting”), and therefore, will no longer serve as a director of the Company or on any committee of the Board, effective as of the Annual Meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1372299/000110465922036781/0001104659-22-036781-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not stand for re-election"},{"label":"Role","value":"Class II Director"}],"fact_type":"executive_change"},{"claim_id":"8d563292bb","claim":"Marna Whittington was appointed as Class II Director at Ocugen, Inc..","evidence_excerpt":"On March 17, 2022, the Board increased the size of the Board from seven to eight members, and appointed Marna Whittington, Ph.D. as a Class II director, effective March 21, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1372299/000110465922036781/0001104659-22-036781-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class II Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}